|

Toripalimab+Chemotherapy Clinical Trials

2 actively recruiting trials across 1 location

Also known as: Carboplatin, Cisplatin, Docetaxel

Other1 trial

ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC
Phase 2

Baltimore, Maryland1 trial

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

Johns Hopkins Hospital East Baltimore

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.